JP2007519691A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519691A5
JP2007519691A5 JP2006550247A JP2006550247A JP2007519691A5 JP 2007519691 A5 JP2007519691 A5 JP 2007519691A5 JP 2006550247 A JP2006550247 A JP 2006550247A JP 2006550247 A JP2006550247 A JP 2006550247A JP 2007519691 A5 JP2007519691 A5 JP 2007519691A5
Authority
JP
Japan
Prior art keywords
atom
group
nucleus
carbon atoms
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006550247A
Other languages
English (en)
Japanese (ja)
Other versions
JP5047629B2 (ja
JP2007519691A (ja
Filing date
Publication date
Priority claimed from FR0400913A external-priority patent/FR2865732B1/fr
Application filed filed Critical
Publication of JP2007519691A publication Critical patent/JP2007519691A/ja
Publication of JP2007519691A5 publication Critical patent/JP2007519691A5/ja
Application granted granted Critical
Publication of JP5047629B2 publication Critical patent/JP5047629B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006550247A 2004-01-30 2005-01-31 ヒドラジドタイプの化合物及び心臓血管系疾患の治療のための製薬組成物の調製における該化合物の使用 Expired - Fee Related JP5047629B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0400913 2004-01-30
FR0400913A FR2865732B1 (fr) 2004-01-30 2004-01-30 Composes de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires
PCT/FR2005/000199 WO2005082882A1 (fr) 2004-01-30 2005-01-31 Composes de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires

Publications (3)

Publication Number Publication Date
JP2007519691A JP2007519691A (ja) 2007-07-19
JP2007519691A5 true JP2007519691A5 (https=) 2011-07-07
JP5047629B2 JP5047629B2 (ja) 2012-10-10

Family

ID=34746342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006550247A Expired - Fee Related JP5047629B2 (ja) 2004-01-30 2005-01-31 ヒドラジドタイプの化合物及び心臓血管系疾患の治療のための製薬組成物の調製における該化合物の使用

Country Status (15)

Country Link
US (1) US20070161697A1 (https=)
EP (2) EP2113502B1 (https=)
JP (1) JP5047629B2 (https=)
CN (1) CN100588655C (https=)
AT (1) ATE444961T1 (https=)
AU (1) AU2005217174B2 (https=)
BR (1) BRPI0507248A (https=)
CA (1) CA2554439A1 (https=)
DE (1) DE602005017007D1 (https=)
DK (1) DK2113502T3 (https=)
ES (2) ES2398479T3 (https=)
FR (1) FR2865732B1 (https=)
PT (2) PT1709027E (https=)
WO (1) WO2005082882A1 (https=)
ZA (1) ZA200606909B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006132583A1 (en) * 2005-06-07 2006-12-14 Innate Pharmaceuticals Ab Method and means for preventing and inhibiting respiratory disease, atherosclerosis and osteoporosis caused by chlamydia pneumoniae infection
EP2338879A1 (en) 2009-12-15 2011-06-29 Arteria New phenylhydrazone derivatives and their use as pharmaceuticals
WO2012027548A1 (en) * 2010-08-25 2012-03-01 The Feinstein Institute For Medical Research Compounds and methods for prevention and treatment of alzheimer's and other diseases
CN103044284A (zh) * 2011-10-13 2013-04-17 南京大学 香草酸酰腙类衍生物及其制备和用途
WO2014028946A2 (en) * 2012-08-17 2014-02-20 The Broad Institute, Inc. Modulators of hepatic lipoprotein metabolism
CN103613514B (zh) * 2013-10-30 2015-05-13 西北师范大学 荧光比色识别氰根离子的有机双金属凝胶及其制备和应用
CN104860866B (zh) * 2015-05-25 2018-07-17 厦门大学 5-(取代碳酰氨基)-1h-吲哚-2-碳酰肼衍生物及其制备方法和应用
CN104829597B (zh) * 2015-05-25 2018-07-17 厦门大学 1h-吲哚-2-碳酰肼衍生物及其制备方法和用途
CN105348170B (zh) * 2015-11-06 2019-02-05 厦门大学 1-(2-(碳酰肼取代基团)-1h-吲哚-5-基)-3-取代脲衍生物及制备方法
WO2018107853A2 (en) 2016-09-26 2018-06-21 Qingdao Primedicine Pharmaceutical Co., Ltd. N-methyl-d-aspartate receptor allosteric modulators and methods for their use
PL233208B1 (pl) * 2018-09-17 2019-09-30 Politechnika Wroclawska Iminowe pochodne aldehydów salicylowych i hydrazydu kwasu 4-hydroksybenzoesowego oraz sposób ich wytwarzania
WO2023060161A1 (en) * 2021-10-06 2023-04-13 The Research Foundation For The State University Of New York Anti-fungals compounds targeting the synthesis of fungal sphingolipids

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB762187A (en) * 1952-10-09 1956-11-28 Bayer Ag Metal complexes of hydrazide-hydrazones and process for producing the same
JPS4819628B1 (https=) * 1969-01-07 1973-06-14
US3859281A (en) * 1971-07-01 1975-01-07 American Home Prod 2,6-dichlorobenzylidenehydrazides
US3829492A (en) * 1972-02-04 1974-08-13 Rohm & Haas Fungicidal salicylaldehyde hydrazones and azines
US3963480A (en) * 1973-04-11 1976-06-15 Sterling Drug Inc. Herbicidal pyrrole-2-carboxamides
JPS62501709A (ja) * 1985-02-11 1987-07-09 ジ・アップジョン・カンパニ− 駆虫薬ピリジニル・アシルヒドラゾン、その使用方法および組成物
US5424333A (en) * 1985-10-21 1995-06-13 Rohm And Haas Company Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines
US6005113A (en) * 1996-05-15 1999-12-21 Molecular Probes, Inc. Long wavelength dyes for infrared tracing
JPH11106371A (ja) * 1997-07-04 1999-04-20 Nisshin Flour Milling Co Ltd アシルヒドラゾン誘導体
JP2001233767A (ja) * 2000-02-25 2001-08-28 Shionogi & Co Ltd アポai発現亢進剤
WO2002102301A2 (en) * 2000-12-07 2002-12-27 Cytovia, Inc. Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
US20040110963A1 (en) * 2001-01-22 2004-06-10 Kaspar Burri Novel hydrazones
DE20108608U1 (de) * 2001-05-23 2001-08-09 Wella Ag, 64295 Darmstadt 2,5-Diamino-benzaldehyd-Derivate und diese Verbindungen enthaltende Färbemittel
EP1462105A1 (en) * 2003-03-28 2004-09-29 Procorde GmbH Activation specific inhibitors of NF-kB and method of treating inflammatory processes in cardio-vascular diseases
DE10348022A1 (de) * 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
EP2022495B1 (en) * 2006-05-31 2014-07-23 Mochida Pharmaceutical Co., Ltd. Composition for preventing the occurrence of cardiovascular event in multiple risk patient

Similar Documents

Publication Publication Date Title
JP2007519691A5 (https=)
JP2010504286A5 (https=)
JP2007514646A5 (https=)
JP2009511490A5 (https=)
JP2015143283A5 (https=)
JP2005053931A5 (https=)
JP2005289914A5 (https=)
JP2005500311A5 (https=)
JP2005519048A5 (https=)
WO2009077874A3 (en) A pharmaceutical composition for treating esophageal cancer
ATE391144T1 (de) Organopolysiloxan und dieses enthaltende härtbare silikonzusammensetzung
JP2001146514A5 (https=)
DE602004012858D1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
JP2016518437A5 (https=)
JP2007519618A5 (https=)
KR960706477A (ko) 신규한 이미다졸 유도체 및 이의 제조방법(Novel imidazole derivative and process for producing the same)
ATE388146T1 (de) 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
JP2010520214A5 (https=)
JP2005525392A5 (https=)
JP2004083852A5 (https=)
NO20075734L (no) Tiofenforbindelser og trombopoietin reseptoractivatorer
JP2005538944A5 (https=)
DE602005014804D1 (de) Substituierte 5-carboxyamidpyrazoles und ä1,2,4ütriazole als viruzide
JP2007517826A5 (https=)
HUP0102867A2 (hu) Eljárás morfolinszármazékok előállítására